Bleichroeder LP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bleichroeder LP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,736,564
-37.0%
755,0280.0%0.43%
-23.4%
Q2 2023$2,755,852
+2.2%
755,0280.0%0.56%
-2.8%
Q1 2023$2,695,450
+9.8%
755,028
-12.3%
0.58%
+7.9%
Q4 2022$2,454,642
+98.3%
861,278
+55.2%
0.53%
+106.6%
Q3 2022$1,238,000
-10.4%
555,0000.0%0.26%
-9.5%
Q2 2022$1,382,000
-48.7%
555,000
+0.5%
0.28%
-40.4%
Q1 2022$2,694,000
+19.1%
552,000
+176.0%
0.48%
+35.4%
Q4 2021$2,262,000
-11.3%
200,000
+14.3%
0.35%
-14.7%
Q3 2021$2,550,000
+25.1%
175,0000.0%0.41%
+34.4%
Q2 2021$2,039,000
+11.4%
175,000
+16.7%
0.31%
+97.4%
Q1 2021$1,830,000
+95.1%
150,000
+100.0%
0.16%
-14.8%
Q4 2020$938,000
-58.5%
75,000
-50.0%
0.18%
-54.7%
Q3 2020$2,258,000
-44.2%
150,000
-9.1%
0.40%
-43.5%
Q2 2020$4,044,000
+72.7%
165,0000.0%0.72%
+16.8%
Q1 2020$2,341,000
-10.6%
165,0000.0%0.61%
+47.5%
Q4 2019$2,619,000165,0000.42%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Corriente Advisors, LLC 820,000$11,636,00012.56%
Prosight Management, LP 552,060$7,834,0003.66%
Nantahala Capital Management 2,503,840$35,529,0001.33%
MANGROVE PARTNERS IM, LLC 601,398$8,534,0001.18%
Voss Capital, LLC 88,670$749,0001.00%
Slate Path Capital LP 870,694$12,355,0000.95%
Avoro Capital Advisors LLC 1,870,000$26,535,0000.90%
Bleichroeder LP 165,000$2,341,0000.61%
683 Capital Management, LLC 640,000$9,082,0000.54%
PA Capital LLC 40,706$578,0000.51%
View complete list of CUE BIOPHARMA INC shareholders